Ibuprofen-loaded calcium phosphate granules: Combination of innovative characterization methods to relate mechanical strength to drug location
Source abstract
Abstract
This paper studies the impact of the location of a drug substance on the physicochemical and mechanical properties of two types of calcium phosphate granules loaded with seven different contents of ibuprofen, ranging from 1.75% to 46%. These implantable agglomerates were produced by either low or high shear granulation. Unloaded Mi-Pro pellets presented higher sphericity and mechanical properties, but were slightly less porous than Kenwood granules (57.7% vs 61.2%). Nevertheless, the whole expected quantity of ibuprofen could be integrated into both types of granules. A combination of surface analysis, using near-infrared (NIR) spectroscopy coupling chemical imaging, and pellet porosity, by mercury intrusion measurements, allowed ibuprofen to be located. It was shown that, from 0% to 22% drug content, ibuprofen deposited simultaneously on the granule surface, as evidenced by the increase in surface NIR signal, and inside the pores, as highlighted by the decrease in pore volume. From 22%, porosity was almost filled, and additional drug substance coated the granule surfaces, leading to a large increase in the surface NIR signal. This coating was more regular for Mi-Pro pellets owing to their higher sphericity and greater surface deposition of drug substance. Unit crush tests using a microindenter revealed that ibuprofen loading enhanced the mechanical strength of granules, especially above 22% drug content, which was favorable to further application of the granules as a bone defect filler.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Dental materials and restorations · Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Influence of Mg-substitution on the physicochemical properties of calcium phosphate powders10.1016/j.materresbull.2006.09.015 ↗
2. Morphological, mechanical, and biocompatibility characterization of macroporous alumina scaffolds coated with calcium phosphate/PVA10.1007/s10853-007-1849-6 ↗
3. Calcium phosphate materials in restorative dentistry: a review10.1177/08959374880020011101 ↗
4. Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization10.1002/jbm.820230806 ↗
5. Macroporous calcium phosphate ceramics for long bone surgery in human and dogs—clinical and histological studies
6. Compatibility of porous ceramics with soft tissue; application to tracheal prostheses10.1002/jbm.820050616 ↗
7. The use of ceramics for bone replacement: a comparative study of three different porous ceramics10.1302/0301-620X.66B2.6323483 ↗
8. Effect of the macroporosity for osseous substitution of calcium phosphate ceramics
9. Quantification of bone ingrowth into porous block hydroxyapatite in humans10.1002/(SICI)1097-4636(199910)47:1<54::AID-JBM7>3.0.CO;2-P ↗
10. A novel skeletal drug-delivery system using self-setting calcium phosphate cement. 4. Effect of the mixing solution volume on the drug-release rate of heterogeneous aspirin-loaded cement10.1002/jps.2600830230 ↗
11. Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system10.1021/js960405a ↗
12. Preparation, characterization and in vitro release of gentamicin from coralline hydroxyapatite–chitosan composite microspheres10.1016/S0144-8617(01)00331-9 ↗
13. Calcium phosphate cements as drug delivery systems: a review10.1016/j.jconrel.2006.04.007 ↗
14. High release of antibiotic from a novel hydroxyapatite with bimodal pore size distribution10.1002/jbm.b.30047 ↗
15. From porous pellet fabrication to drug loading and release: the case of calcium phosphate matrix loaded with ibuprofen
16. Chevalier E, Viana M, Cazalbou S, Chulia D. Validation of a manufacturing process of pellets for bone filling and drug delivery. J Drug Del Sci Tech 2008;18(6):438–44.10.1016/S1773-2247(08)50084-0 ↗
17. Chevalier E, Viana M, Cazalbou S, Chulia D. Comparison of low shear and high shear granulation processes: effect on implantable calcium phosphate granule properties. Drug Dev Ind Pharm. doi: 10.1080/03639040902882298.10.1080/03639040902882298 ↗
18. Bioactive glass-polymer materials for controlled release of ibuprofen10.1016/S0142-9612(03)00279-5 ↗
19. Effects of calcination temperature on the drug delivery behaviour of ibuprofen from hydroxyapatite powders10.1007/s10856-007-3185-4 ↗
20. Injectable self-curing bioactive acrylic-glass composites charged with specific anti-inflammatory/analgesic agent10.1016/j.biomaterials.2003.09.004 ↗
21. Bone-regenerative bioceramic implants with drug and protein controlled delivery capability10.1016/j.progsolidstchem.2007.10.002 ↗
22. Assessment of acrylic bone cement as a local delivery vehicle for the application of non-steroïdal anti-inflammatory drugs10.1016/S0142-9612(98)00012-X ↗
23. Release of ibuprofen from poly(-caprolactone-co-d,l-lactide) and simulation of the release10.1002/app.11806 ↗
24. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of labrafil addition on release in vitro10.1016/j.ijpharm.2004.04.003 ↗
25. Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier10.1016/j.biomaterials.2008.07.042 ↗
26. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property10.1016/j.ejpb.2003.12.007 ↗
27. A novel application of the T cell for the flow through dissolution: the case of bioceramics used as ibuprofen carrier10.1016/j.talanta.2008.09.046 ↗
28. Chevalier E, Viana M, Artaud A, Chomette L, Haddouchi S, Devidts G, et al. Comparison of three dissolution apparatuses for testing calcium phosphate pellets used as ibuprofen delivery systems, AAPS PharmSciTech, in press. doi: 10.1208/s12249-009-9252-z.10.1208/s12249-009-9252-z ↗
29. Impact test for hardness of compressed powder compacts10.1002/jps.2600600521 ↗
30. Hardness, toughness and brittleness of ceramics: an indentation analysis10.1111/j.1151-2916.1979.tb19075.x ↗
31. Determination of Youngs modulus by spherical indentation10.1557/JMR.1997.0325 ↗
32. Indentation brittleness of ceramics: a fresh approach10.1023/A:1018671823059 ↗
33. Measurement and characterization of particle strength using a new robotic compression tester10.1016/j.powtec.2004.04.007 ↗
34. A novel technique for imaging film coating defects in the film-core interface and surface of coated tablets10.1016/S0939-6411(03)00118-8 ↗
35. Analysis of coating structures and interfaces in solid oral dosage forms by three dimensional tetrahertz pulsed imaging10.1002/jps.20789 ↗
36. Novel identification of pseudopolymorphic changes of theophylline during wet granulation using near infrared spectroscopy10.1002/1520-6017(200103)90:3<389::AID-JPS13>3.0.CO;2-9 ↗
37. Detection of Lipitor® counterfeits: a comparison of NIR and Raman spectroscopy in combination with chemometrics10.1016/j.jpba.2008.02.016 ↗
38. The use of low temperature Van der Waals adsorption isotherm in determining surface area10.1021/ja01269a023 ↗
39. About pycnometric density measurements10.1016/S0039-9140(02)00058-9 ↗
40. Validation of a new pertinent packing coefficient to estimate flow properties of pharmaceutical powders at a very early development stage, by comparison with mercury intrusion and classical flowability methods10.1023/A:1017528809955 ↗
41. European Pharmacopoeia. 6th ed. Council of Europe, Strasbourg; 2006.
42. Lewis EN, Schoppelrei J, Lee E, Kidder LH. Near-Infrared chemical imaging as a process analytical tool. In: Bakeav KA, editor. Process Analytical Technology. Oxford: Blackwell Publishing; 2005. p. 45.10.1002/9780470988459.ch7 ↗
43. NIR chemical imaging for counterfeit pharmaceutical products analysis
44. Measurement of drug agglomerates in powder blending simulation samples by near infrared chemical imaging10.1016/j.ijpharm.2007.08.055 ↗